We used microarray analysis to identify other targetable pathways in intrahepatic CCA [10, 11] and identified a novel sphingosine-1-phosphate (S1P) pathway and a potential drug target, sphingosine kinase 1 (SPHK1). Here, SPHK1 is linked to cholangiocarcinoma.